Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment

NCT ID: NCT02827214

Last Updated: 2023-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

213 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thoracolumbar (TL) burst fractures in neurologically intact patients account for approximately 45% of all TL spine injuries. Despite being common fractures, there is significant variability in treatment recommendations encompassing surgery and non-surgical treatment options. The controversy regarding optimal treatment for these injuries is fueled by several studies which suggest a potential benefit to surgical treatment in the realm of patient satisfaction, and the overall socio-economic burden of treatment while other studies demonstrate improved outcomes and lower morbidity with non-surgical treatment. This study aims to perform a prospective cohort analysis investigating the clinical outcome of various treatment alternatives for patients with A3/A4 fractures in the thoracolumbar region. A cost-effectiveness analysis will also be performed to identify costs and benefits of each treatment option. More specifically a sub-group analysis will be performed for this group of patients, which have equipoise in regards to patients treatment, as decided by a blinded review panel.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

208 subjects (i.e., 137 per surgical group; 71 per conservative group) with TL burst fractures AOSpine classification type A3 or A4 without neurological deficit as defined in the inclusion/exclusion criteria, and with or without suspected Posterior Ligament Complex (PLC) injury (M1) from T10 to L2, will be enrolled in a prospective multicenter cohort study. Patients may have an associated B injury, but must have an A3 or A4. Patients will be monitored prospectively for patient reported, clinical and radiologic outcomes, over a period of 2 years post-treatment. Specifically a patient diary will measure the Oswestry Disability Index (ODI), and employment information (indirect costs questionnaire) every second week until 6 months post-treatment. Diary will continue every second month until 2 years post-treatment. All interventions/examinations are considered as standard of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracolumbar Burst Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical treatment

Several surgical treatments exist to treat the fractures included in the study. The following section describes the different surgical treatment modalities in more detail

Approaches:

* Open short segment surgical fixation (1 level above and below the fracture level) with or without posterior decompression
* Open long segment posterior fixation (2 or more levels above, 2 or more levels below) with or without posterior decompression
* Posterior short or long fixation with posterolateral corpectomy and reconstruction
* Anterior alone instrumentation
* Combined Anterior Posterior (AP) instrumentation
* Percutaneous posterior fixation combined with anterior instrumentation
* Percutaneous posterior fixation with or without vertebroplasty

No interventions assigned to this group

Non-surgical treatment

Non-surgical treatment is defined as bed rest followed by immobilization with:

* Custom-molded or prefabricated total body contact thoracolumbosacral orthosis (TLSO)
* Thermoplastic removable brace
* Jewett hyperextension braces
* Anterior hyperextension brace (ASH)
* Taylor-Knight brace
* Plaster of Paris (POP)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Skeletally mature, age 18 to 65 years old inclusive
* Diagnosis of AO type A3 or A4 fractures on a CT scan with or without a suspected PLC injury (M1) from T10 to L2.
* Patients may have an associated B injury, but must have an A3 or A4.
* TLICS Score between 2-5 inclusive
* Acute fracture - diagnosis and treatment within 10 days of injury
* Ability to understand the content of the patient information / informed consent form
* Willingness and ability to participate in the clinical investigation including imaging and FU procedures
* Investigation according to the Clinical Investigation Plan (CIP)
* Signed and dated IRB/EC-approved written informed consent

Exclusion Criteria

* Any neurological deficit associated with the fracture. Absence of neurological deficit will be determined with the International Standards for Neurological Classification of Spinal Cord Injury (ISNC SCI). It will be documented the status "E" (neurologically intact/normal) of the patient.
* Spontaneous fractures due to pathologic processes or neoplasia
* Head injuries causing inability to cooperate during hospital admission
* Open or penetrating spinal lesion (e.g. due to gun, stab, or projectile)
* Prior spinal surgeries in thoracic or lumbar spine
* Additional musculoskeletal, head or other injuries which would preclude rapid mobilization
* Multiple trauma or Injury Severity Score (ISS) \> 16
* Other co-morbidities precluding the patient to be considered as a surgical or non-surgical candidate, i.e. burns, dementia, BMI \> 40, etc.
* Any severe systemic medical disease that would exclude the patient to be a potential candidate for surgery
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
* Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment.
* Pregnancy or women planning to conceive within the study period
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Foundation, AO Spine

OTHER

Sponsor Role collaborator

AO Innovation Translation Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcel Dvorak, MD

Role: PRINCIPAL_INVESTIGATOR

Vancouver General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, San Diego Medical Center

San Diego, California, United States

Site Status

SUNY Upstate

East Syracuse, New York, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

West Virginia University

Morgantown, West Virginia, United States

Site Status

Alfred Health operating through the Alfred hospital

Melbourne, , Australia

Site Status

Hopital l'Enfant-Jesus, CHU de Quebec

Québec, , Canada

Site Status

Vancouver General Hospital

Vancouver, , Canada

Site Status

Assiut University Hospitals

Asyut, , Egypt

Site Status

KAT Hospital

Kifissia, , Greece

Site Status

Ganga Hospital

Coimbatore, , India

Site Status

UMC Utrecht

Utrecht, , Netherlands

Site Status

Clinical Hospital "Prof. N.Oblu"

Iași, , Romania

Site Status

Hospital Universitario Costa del Sol

Marbella, , Spain

Site Status

Inselspital, University of Bern

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada Egypt Greece India Netherlands Romania Spain Switzerland

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Spine_TL-A3-A4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mangement of Spine Fracture
NCT06458309 RECRUITING NA
StUdy oN Burst Fractures (SunBurst)
NCT05003180 ACTIVE_NOT_RECRUITING NA